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Abstract
In mammalian cells, when tandem affinity purification (TAP) approach is employed, the existence 
of untagged endogenous target protein and repetitive washing steps together result in overall low 
yield of purified/stable complexes and the loss of weakly and transiently interacting partners of 
biological significance. To avoid the trade-offs involving in methodological sensitivity, precision, 
and throughput here we introduce an integrated method, biotin tagging coupled with amino acid-
coded mass tagging (BioCAT) for highly sensitive and accurate screening of mammalian protein-
protein interactions (PPIs). Without the need of establishing a stable cell line, using a short peptide 
tag which could be specifically biotinylated in vivo, the biotin-tagged target/bait protein was then 
isolated along with its associates efficiently by streptavidin magnetic microbeads in a single step. 
In a pulled-down complex amino acid-coded mass tagging (AACT) serves as ‘in-spectra’ 
quantitative markers to distinguish those bait-specific interactors from non-specific background 
proteins under stringent criteria. Applying this BioCAT approach, we first biotin-tagged in vivo a 
multi-functional protein family member, 14-3-3ε, which was expressed at close to endogenous 
level. Starting with approximately 20 millions of 293T cells which were significantly less than 
what needed for a TAP run, 266 specific interactors of 14-3-3ε were identified in high confidence.
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Cellular functions, either under normal or pathological conditions, or different stresses, are 
the results of the coordinated action of multiple proteins interacting in macromolecular 
complexes or assemblies [1-4]. Therefore, precise determination of specific composition of 
protein complexes, especially using scalable and high-throughput methods, represents a 
systematic approach toward revealing particular cellular biological functions [2-6].
Immunoprecipitations (IP) via available antibodies against target proteins are commonly 
used to selectively enrich and pull-down target protein and its interacting partners for 
concurrent MS analysis of their identities [3, 4, 7]. However, in an IP complex pull-down 
experiment the antibody against the target protein may interfere with the binding sites on the 
target protein for recruiting its interactors. Tagging the target gene with known epitope 
sequence(s) followed by IP experiments using epitope-specific antibody becomes a popular 
way to pull down target protein-specific protein complexes. This type of approaches allows 
for ‘opening’ these binding sites at the target protein for its partners so that the naturally 
occurring endogenous interactions can be preserved. As a commonly used approach of the 
epitope tagging strategy, tandem affinity purification (TAP) was developed to isolate target 
protein-specific interacting complexes in high purity [5, 7, 8]. The rationale behind TAP tag 
method is that the contaminating proteins bound non-specifically to the bait protein can be 
removed by multiple steps of epitope-based affinity purifications [7, 8]. In addition to the 
tedious step of establishing a cell line that stably expresses TAP-tagged target/bait protein, 
the repetitive washing not only demands for considerable amounts of the cells starting with 
for purification to homogeneity (typically around 109 cells), but also, as a trade-off for high 
complex purity, can lead to the loss of weak or transient interactions of biological relevance.
In MS analysis ‘in-spectra’ quantitative markers can be introduced through metabolic 
incorporation of stable isotope-enriched amino acids using our amino acid-coded mass 
tagging (AACT) approach [9, 10], or stable isotope labeling by amino acids in cell culture 
(SILAC as named by another group) [11], to improve the sensitivity, accuracy, and 
throughput of measuring protein abundance changes [9, 11, 12]. We have previously 
developed a ‘dual-tagging’ (both epitope tag and stable isotope tag) quantitative proteomic 
method [13-15] that integrates the capabilities of natural complex formation, epitope affinity 
isolation, and ‘in-spectra’ quantitative markers to systematically distinguish those 
interacting proteins from a large non-specific binding background. The sensitive detection of 
signal proteins can then be achieved with a single isolation step which can minimize the loss 
of weakly or transiently interacting partners. However, unlike the recombination mechanism 
capable of completely ‘knock-outing’ the untagged endogenous version of target protein in 
yeast cells [16], in mammalian cells the residual expression of the endogenous untagged 
target protein can lead to the competition with its epitope-tagged counterpart for recruitment 
of its interacting partners, which could lower the yield of pulling down the target-specific 
complex [7, 8]. It is a reasonable assumption that an epitope tag with stronger affinity could 
allow for higher recovery of tagged bait and hence its interacting partners in the pulled down 
complex. Because biotin-avidin binding is the strongest non-covalent interaction known in 
nature, a high-affinity isolation of protein complex could be achieved through biotinylating a 
target protein by co-expressing bacterial BirA biotin ligase and then purifying the biotin-
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tagged protein using streptavidin beads [17]. To further improve the specificity, accuracy, 
and sensitivity of our dual-tagging strategy, here we introduce a convenient and efficient 
method for screening interaction proteome or interactome in mammalian cells by using in 
vivo biotin tagging coupled with amino acid-coded mass tagging or we named as BioCAT. 
We showed that a target protein with a short artificial tag of 15 amino acids [18, 19] could 
be specifically biotinylated either in vitro or in vivo. Through transient co-transfection with 
BirA biotin ligase the biotin-tagged target protein was biotinylated in vivo. Also the biotin-
tagged target protein was expressed at lower or close to the level of endogenous untagged 
counterpart which allows us to profile target protein-specific interactions at physiologically 
relevant conditions.
In our model system of biological interest, the 14-3-3 proteins, that are small, acidic, and 
abundant proteins with propensity to form both homo- and heterodimers, belong to a family 
of conserved regulatory molecules expressed in all eukaryotic cells. In mammals seven 
isoforms including 14-3-3β, γ, ε, η, σ, θ (or τ) and ζ are known to possibly interact with 
more than 300 target proteins [20-22]. These isoforms have high homology with 
approximately 50% amino acid identity [22]. There is no apparent single conserved function 
for all members of 14-3-3 family instead one can hypothesize that each type of 14-3-3 
isomers can be differentially involved in regulating various cellular processes through 
interacting with different groups of functionally characteristic proteins [20-23]. As the first 
step to reveal the multi-functional nature of the least characterized 14-3-3 isomer, 14-3-3ε, 
we illustrate the unique strength of this BioCAT approach for screening 14-3-3ε-specific 
interactome. Note that compared to a TAP-based method of QTAX [16] which was 
demonstrated only for yeast cells, our method bypasses tedious procedure of establishing 
stable cell line, meanwhile our parallel uses of a single high affinity tag instead of TAP tag 
for high yield pull-down and amino acid tags for increasing signal specificity will ensure the 
efficiency and accuracy of distinguishing specific protein interactions in mammalian cells.
2 Methods
2.1 Plasmid/Vector Generation
The DNA sequence coding for the 15-aa acceptor peptide (AP) tag 
(GLNDIFEAQKIEWHE, refs. 18, 19) is amplified by PCR by using two partly 
complementary primers. The sequences of the primers used in our experiments were given 
as follows: for the AP-tag at N-terminus, the sense primer 5′-
CACCATGTCCGGCCTGAACGACATCTTCGAGGC TCAGAAAATCG-3′, antisense 5′-
TTCGTGCCATTCGATTTTCTGAGCCTCG-3′ ; for the AP-tag at C-terminus, sense 5′-
CACCTCCGGCCTGAACGACATCTT CGAGGCTCAGAAAATCG-3′, antisense 5′-
TCATTCGTGCCATTCGATTTTCTGAGCCTCG-3. The coding region of the Escherichia 
coli birA biotin–protein ligase gene was amplified from genomic DNA by PCR using the 
primers with sense 5′-CACCATGAAGGATAACACCGTGCCACTG-3′ and antisense 5′-
GGTAGAAGAGGTCAGACTACGC-3. These PCR products were then introduced directly 
into the expression vector pcDNA3.1 using the directional TOPO Cloning technology 
(Invitrogen). The constructs were then named as pAP-C, pAP-N and pBirA, respectively. 
The cDNAs coding for VAV1, a signaling mediator in many types of immune cells, and 
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14-3-3ε were amplified by RT-PCR from NK92MI cell and 293T cell, respectively, and then 
introduced into the corresponding restriction enzyme sites of pAP-C or pAP-N (Hind III/
BamH I or EcoR V/Xba I) to generate new expression vectors, where the AP tag is 
genetically encoded at the C terminus or N terminus of the protein of interest. The vectors 
were then named as pVAV1-AP for carrying the VAV1 gene with the AP tag at the C-
terminus; p1433-AP for carrying the 14-3-3ε gene with the AP tag at the C-terminus; and 
pAP-1433 for carrying the 14-3-3ε gene with the AP tag at the N-terminus. The primers 
used for these constructs were as follows: pVAV1-AP, sense 5′-
GCTTATCAAGCTTAGGCGGTAGCCATGGAG-3′, antisense 5′-
GCACCGGATCCCAGCAGTATTCAGAATAATC-3′ ; pAP-1433, sense 5′-
CGTTGATATCGATGATCGAGAGGATCTGGTG-3′, antisense 5′-
CCAGTCTAGATCACTGATTTTCGTCTTCCACG-3′ ; p1433-AP, sense 5′-
CGACGACAAGCTTATGGATGATCGAGAGGATCTGG-3′, antisense 5′-
CTATGGGATCCTGATTTTCGTCTTCCACGTC-3. All vectors were verified by 
sequencing.
2.2 Reagents
Recombinant biotin ligase BirA and AP-tagged standard protein, MBP-AviTag either fully 
biotinylated or un-biotinylated was obtained from Avidity (Denver, CO). Anti-14-3-3ε 
antibody was obtained from Chemicon (Temecula, CA). Anti-14-3-3ζ antibody was 
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-NonO antibody was 
obtained from Protein Tech Group (Chicago, IL). Leucine-d3 was purchased from 
Cambridge Isotope Laboratories (Andover, MA).
2.3 Cell Culture and Transfection
The 293 and 293T cells were cultured in DMEM (Invitrogen, Calsbad, CA) supplemented 
with 10% FBS (Invitrogen), 1% penicillin, and 100 μg/mL streptomycin. The NK92MI cells 
were cultured in α-MEM (Invitrogen) supplemented with 12.5% fetal calf serum, 12.5% 
horse serum, 0.2 mM inositol, 0.1 mM -mercaptoethanol and 0.02 mM folic acid. The 
hepatocellular carcinoma cell line 7703 was cultured in RPMI-1640 (Invitrogen) 
supplemented with 10% FBS. The 293T cells for AACT were maintained in DMEM with 
leucine replaced with leucine-d3 until the leucine-d3 was fully incorporated into cellular 
proteins [10, 11]. Transient transfection of 293T cells was performed in 6-well plate by 
using FuGENE HD transfection reagent according to the manufacture’s instruction (Roche 
Diagnostics, Indianapolis, IN). For comparative analysis we used same total amount of 
plasmids when transfecting the cells either with one type of plasmids or co-transfecting with 
both types of plasmids.
2.4 Immunoblot Analysis
The proteins were resolved by SDS-PAGE and then transferred to a nitrocellulose 
membrane (Millipore, Bedford, MA). For analysis of biotinylation, filters were blocked for 
1 h in 5% BSA/1×TBS/0.1% Tween-20 and incubated for 1 h at room temperature with 
streptavidin–horseradish peroxidase conjugate (HRP). For the analysis of protein expression, 
filters were incubated with the specified primary antibody followed by incubation with a 
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secondary antibody conjugated with HRP. The ECL substrate was then added and the blot 
was developed.
For the purpose of validating newly identified 14-3-3ε interacting partners, the 293T cells 
were transiently transfected alone with the expression plasmid pBirA or co-transfected with 
both plasmids as indicated. Forty hours after the transfection, the biotin-tagged AP-1433 and 
its interactors were pulled down together by streptavidin microbeads and then separated by 
SDS-PAGE for Western blotting against, e.g., anti-streptavidin or anti-14-3-3 or anti-NonO 
antibodies.
2.5 In vitro Biotinylation
The cells were lysed in the lysis buffer (20 mM Tris-HCl, 150 mM NaCL, 1% Triton X-100) 
supplemented with protease inhibitor cocktail (P8340, Sigma, St. Louis, MO). The cellular 
soluble extracts (200 μl) were then transferred into a Microcon centrifugal filter (YM-3, 
3000 molecular weight cutoff, Millipore) to desalt. The Microcon tube was spun at 14,000 × 
g for 1 h, after which about 25 μl remained. The sample in the Microcon was diluted in 100 
μl of dilution buffer (10 mM Tris-HCl, pH 8.0) and respun for 40 min, and the cycle 
repeated twice, with a final volume of about 50 μl. For biotinylation, recombinant biotin 
ligase BirA was added to the desalted protein solution with ATP and biotin for 1 hr at 30°C, 
according to the manufacture’s protocol.
2.6 One-step Purification
The biotin-tagged proteins were purified by using streptavidin magnetic microbeads through 
magnetic sorting according to the manufacturer’s instructions. For purification of the 
standard protein, 0.22 or 0.67 μg of MBP-AviTag protein was diluted in 200 μl of binding 
buffer(10 mM Tris-HCl, pH 8,0.5% BSA) and then incubated with 100 ul of streptavidin 
magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). For purification of 
the tagged proteins that have been biotinynated in vivo by co-expressed BirA ligase, the 
cellular soluble extracts (200 μl) were directly incubated with 100 ul of streptavidin 
magnetic microbeads in the lysis buffer. The biotin-avidin binding was usually completed in 
seconds as suggested by the manufacturer. After rinsing the μ Column in the magnetic field 
of the μMACS separator with the appropriate equilibration buffer (Miltenyi Biotec) and the 
binding buffer, the binding reaction (following 1 min incubation at room temperature) was 
applied onto the top of the column matrix. The column was then rinsed with the lysis buffer, 
which was used for cell lysis as described above, to remove non-specically binding 
molecules. In the last step, elution of the biotinylated protein was performed by applying 
100 μL of 1× SDS protein loading buffer after removing the column out of the magnetic 
field. For purification of the tagged protein that was biotinynated in vitro, before binding 
with streptavidin microbeads, the protein was first removed free biotin by using Microcon 
centrifugal filter (3000 molecular weight cutoff) as described above. The purified proteins in 
1× SDS protein loading buffer were boiled for 5 min before resolved by SDS-PAGE. The 
gel was stained by Coomassie brilliant blue or silver using standard protocols. We used 
Bandscan 5.0 software for performing the densitometry analysis.
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The procedure for in-gel digestion and peptide extraction was similar to that previously 
described [13, 14]. Nanocapillary liquid chromatography electrospray ionization tandem 
mass spectrometry (nanoLC-MS/MS) was performed on a hybrid linear quadrupole ion trap/
Orbitrap (LTQ Orbitrap) mass spectrometer (Thermo Electron, San Jose, CA). An Agilent 
1100 series nanoflow HPLC is coupled on-line to a nanospray ionization source (Proxeon 
Biosystems) holding a column packed with 3-μm-diameter ReproSil Pur C18 beads into a 
15-cm-long, 75-μm-inner diameter fused silica emitter. The peptide mixture eluted from 
each gel band was separated by using a gradient, Buffer A consists of 0.5% acetic acid, and 
buffer B consists of 0.5% acetic acid and 80% acetonitrile (ACN). The gradient elution was 
run from 6% to 30% ACN over 60 min, then 30% to 80% of Buffer B in the next 10 min, 
held at 80% B for 5 min, and then dropped to 6% B for another 15 min to recondition the 
column. The LTQ-Orbitrap was set to acquire a full-range scan at 60,000 resolution from 
350 to 1500 Th in the Orbitrap and to simultaneously fragment the top five abundant peptide 
ions in each cycle in the LTQ. Because Orbitrap data were to be used for quantitative 
analysis, blank gradients where buffer B was injected were interspersed between two 
analytical gradients to eliminate sample carryovers.
2.8 Protein Identification
MS/MS data was searched against the IPI human protein database (version 3.13) using the 
SEQUEST algorithm (Thermo Electron) incorporated into the BioWorks software (version 
3.2). Searches were performed with modifications on methionine (oxidation), or leucine 
with masses 15.9949 or 3.018 Da respectively. The peptide mass tolerance and fragment 
mass tolerance were at 50 ppm and 1 Da respectively. SEQUEST results were filtered by 
Xcorr in coordinating with the charge state of peptides. Xcorr values of ≥1.9 for singly 
charged ions, ≥2.7 for doubly charged ions, and ≥3.75 for triply charged ions were 
considered as the positive matches. We set Delta Cn≥0.1 and the probability limit ≤0.001. 
MS/MS files were searched with a tryptic enzyme constrain against a forward and decoy 
human IPI protein database using the SEQUEST algorithm to yield an estimated 1% false-
positive rate. Each protein identification requires the matches of at least two peptides.
2.9 Protein Quantitation
The light-to-heavy isotope ratio (L/H) of each leucine-containing peptide was measured by 
selecting ion chromatogram extraction using the PepQuan ICAT software in BioWorks 3.2. 
For the default parameter, we selected leucine as the ‘modified’ amino acid residue with a 
mass shift of 3.0188Da between its light and heavy isotope version within the mass 
tolerance of 0.03. The identified peptides with a minimum score cutoff of 30 were used to 
obtain the L/H ratio for the corresponding proteins. For a protein L/H ratio obtained from 
multiple leucine-containing peptides the standard deviation (sd) was used to calculate the 
accuracy of L/H ratio. The proteins with their L/H sd larger than 20% were checked on their 
MS signals manually to compare the ratio of peak intensity with the area of XIC. Two 
biological replicates of the samples were performed and compared. Only consistent results 
of protein identification and quantitation from both runs were considered as positive and 
were included in our report.
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2.10 Functional analysis by bioinformaticas
Functions of those identified specific interactors were described using gene ontology (GO) 
terms. Gene annotations were performed using the Functional Annotation Tool at DAVID 
site (http://david.abcc.ncifcrf.gov, May 2008 version). For each GO term 
(GOTERM_BP_3), we assembled the group of genes annotated with the term when the 
number of the genes was more than 8.
The analysis of the associations of the identified specific interactors was performed by 
STRING, which is a database of known and predicted protein-protein interactions (PPIs) 
(http://string.embl.de/, May 2008 version).
3 Results
3.1 Efficiency and Specificity of Biotinylation of Target/Bait Protein in Mammalian Cells
An artificial peptide tag of 23 amino acids (aa) has been shown to be biotinylated in vitro by 
bacterial BirA biotin ligase [19] or in vivo in mammalian cells by co-expressed BirA ligase 
[17]. A shorter 15 aa acceptor peptide (AP) tag could be site-specifically biotinylated by 
BirA ligase at the lysine residue within the AP sequence in vitro [19]. It has been reported 
that the surface proteins tagged with an AP tag could be biotinylated in vitro by adding BirA 
ligase to amedium culturing mammalian cells [18]. We selected the shorter AP tag which 
may reduce the effect on target protein-specific interactions to examine the efficiency and 
specificity of in vivo biotinylation in mammalian cells. We then transfected 293T cells with 
both plasmids carrying the genes coded for AP-tagged protein VAV1 (VAV1-AP) and for 
BirA ligase. Our results indicated that the AP tag is unlikely to be recognized and 
biotinylated by endogenous biotin ligases in mammalian cells, such as holocarboxylase 
synthetase, etc [24]. AP-VAV1 was biotinylated in the cells co-expressing BirA, but not in 
those with the absence of BirA (Figure 1A), indicating the AP tag-dependent specificity for 
biotinylation. In addition, we also observed that AP-VAV1 could be biotinylated in vitro by 
recombinant BirA (Figure 1A).
We then placed the AP tag at either the N or the C terminus of 14-3-3ε protein, an important 
multi-functional protein involving in widespread biological processes [20-23]. We observed 
that both terminus versions of AP-tagged 14-3-3ε protein were specifically biotinylated 
either in vivo (Figure 1B, lanes 3 and 4) or in vitro (Figure 1B, lanes 7 and 8). In addition, 
very little nonspecific biotinylation background was observed in the 293T cells expressing 
only BirA (Figure 1B, lanes 2, 3 and 4), or only AP-tagged 14-3-3ε protein (Figure 1B, 
lanes 5 and 6). Using anti-14-3-3ε antibody, both the slower-migrating tagged protein and 
the endogenous 14-3-3ε were detected in the cellular extracts from transfected cells (Figure 
1C). Note that unlike those cells transfected with AP-tagged 14-3-3ε alone, in the case of the 
co-transfection with BirA-expressing vector, the expression level of AP tagged 14-3-3ε 
either at N- or C-terminal was found close to that of the untagged endogenous 14-3-3ε to 
ensure the analysis of the endogenous protein components. For the purpose of comparison, 
the half amount of 14-3-3ε vector was used for the co-transfection compared to when 
transfected with AP-tagged 14-3-3ε alone. Taken together, these results indicate that AP-
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tagged protein could be specifically and efficiently biotinylated by BirA ligase both in vivo 
and in vitro.
3.2 Efficient Purification of Biotin-Tagged Target Protein and Its Associates in Complex 
Using Streptavidin Magnetic Microbeads
Efficient pull-down of the tagged bait protein and its specific associates is critical for protein 
identification by MS which is abundance-based. Because of the strong affinity between 
biotin and streptavidin, biotin-tagged protein could be isolated and purified by using 
streptavidin beads [17, 25]. Here we explored the possibility for convenient and efficient 
purification of biotinylated AP-tagged bait protein by using magnetic streptavidin 
microbeads and then magnetic sorting.
First we used an AP-tagged standard protein, MBP-AviTag (Avidity), to test the purification 
efficiency of magnetic sorting. There are two versions of MBP-AviTag protein, one fully 
biotinylated (B-MBP), and the other un-biotinylated (UB-MBP). B-MBP (Figure 2, lane 2) 
was efficiently captured and purified by streptavidin magnetic microbeads (Figure 2, lane 3), 
while UB-MBP (Figure 2, lane 4) was mostly in the flow through (Figure 2, lane 5). 
Meanwhile we observed a high recovery of B-MBP after the sorting step (Figure 2, lane 2 vs 
lane 3).
We further examined the purification specificity of AP-tagged protein from different 
mammalian cell extracts by using magnetic microbeads. For the mixture of B-MBP with the 
lysate of natural killer NK92MI cells (Figure 2, lane 6), B-MBP was highly purified by 
magnetic microbeads while no nonspecific background proteins were detected (Figure 2, 
lane 7). As a contrast, from the NK92MI cellular lysate treated with BirA ligase in vitro 
(Figure 2, lane 8), no protein (Figure 2, lane 9) was detected, indicating that the NK92MI 
cellular proteins without AP tag were not biotinylated by BirA ligase. In addition, we tested 
the purification scheme using streptavidin magnetic microbeads for a variety of mammalian 
cells such as 293, 293T, and a liver caner cell line treated with BirA ligase in vitro. Similar 
results as shown in Figure 2 were obtained. Taken all results above together, we have 
demonstrated that only AP-tagged protein could be specifically biotinylated and then 
specifically and efficiently purified by streptavidin magnetic microbeads in a single step.
We then utilized the biotinylation-streptavidin magnetic microbead scheme to obtain the 
14-3-3ε-interacting complex formed in mammallen cells. We constructed two plasmids that 
could express the 14-3-3ε protein fused with AP-tag at either N- or C-terminal respectively 
as designated to pAP-1433 or p1433-AP.
Approximately 2.5×106 293T cells were transiently co-transfected with pAP-1433 and BirA 
plasmid or p1433-AP and BirA plasmid respectively. Similarly, we found that the 
expression level of biotin-tagged 14-3-3ε (exogenous) was similar to that of between the 
endogenous14-3-3ε (Figure 1C, lanes 2 and 3). Forty hours after transfection, we isolated 
biotin-tagged 14-3-3ε protein and its associates from the total cell lysate by using 
streptavidin magnetic microbeads. We then separated the pull-down complexes on 1D SDS-
PAGE gel. As shown in Figure 3 (lanes 3 vs 4, lanes 5 vs 6), in the clearly stained bands at 
the size close to AP tagged 14-3-3ε (Figure 1B) where the bait protein was identified, 
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indicating the effectiveness of biotin-tagging for enrichment of the bait protein. Meanwhile, 
multiple distinct bands visible on the gel (Figure 3, lanes 3 vs 4) suggested that possible 
14-3-3ε-interacting proteins were also enriched and pulled down along with the bait protein.
In comparison, we first transfected the same number of 293T cells with either pAP-1433 or 
p1433-AP alone, and then performed the biotinylation experiment on the cellular proteins in 
vitro 40 hours after transfection. After the purification of 14-3-3ε protein complex, we noted 
that the yield of protein complex was significantly lower than what was obtained when using 
in vivo biotinylation method (Figure 3, lanes 3 & 4 vs lanes 5 & 6). Due to additional steps 
needed for in vitro biotinylation and purification (see Methods), we observed less numbers 
of the proteins recovered in vitro compared to those obtained by the in vivo biotinylation 
approach with direct purification by streptavidin magnetic microbeads. These results clearly 
demonstrated the high efficiency and specificity of in vivo biotinylation followed by direct 
purification by streptavidin magnetic microbeads.
Meanwhile, the isolated complex associating with AP-1433 or 1433-AP was separated on a 
1D SDS gel respectively and the similar pattern of protein separation of each complex was 
observed (Figure 3, lane 3 vs lane 4). By using 1D SDS-LC-MS/MS approach as our 
previously described [9,10,13] we identified 78 and 72 proteins respectively in a several of 
parallel gel bands in lane 3 for AP-1433 vs lane 4 for 1433-AP (Figure 3, Supplemental 
Table 1). Among these proteins 61 mutual proteins were found in both pull-down 
complexes. These observations suggested that the 14-3-3ε protein with the biotin tag either 
at N- or C-terminal has the equivalent ability to recruit interacting partners.
3.3 Unambiguous Identification of 14-3-3ε Interacting Partners by Biotin Tagging Coupled 
with Amino Acid-coded Mass Tagging (BioCAT)
We then employed SILAC/AACT ‘in-spectra’ quantitative markers to establish the stringent 
threshold in distinguishing the specific interactors from the non-specific background in the 
pull-down complexes. The overall design of the BioCAT strategy for purification and 
identification of interacting proteins is illustrated in Figure 4. Approximate 2.5 × 106 
parental 293T cells growing in the regular or ‘light’ medium (yellow dishes) were 
transiently transfected with pBirA plasmid expressing BirA ligase and pAP-14-3-3 
expressing AP-14-3-3ε, while the same number of cells growing in the leucine-d3 containing 
or ‘heavy’ medium (green dish) were transiently transfected with only pBirA. Following cell 
lysis each of ‘light’ or ‘heavy’ protein extract was incubated with streptavidin magnetic 
microbeads respectively and the elutes of ‘light’ or ‘heavy’ origin were mixed prior to 1D-
SDS-PAGE separation. The proteins in each of the visible bands were tryptic digested 
followed by LC-MS/MS for relative peptide quantitation and protein identification as our 
previously described [9, 10,13].
In one of the two BioCAT runs, we unambiguously identified 346 proteins in the AP-1433 
complex from 293T cells (Supplemental Table 2) and the distribution of the light-to-heavy 
ratios (L/H) of the identified proteins is summarized in Figure 5. Theoretically, for those 
bait-interacting partners, their peptide abundances in the ‘light’ bait/biotin-specific pull-
down complex should be significantly higher than their ‘heavy’ counterparts.
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Among all proteins identified we found the peptides of many proteins showing the L/H ratio 
less than or close to 1 are non-specific contaminants such as tubulins and carboxylase 
enzymes (Figure 6A and 6B). Noted that tubulins are house-keeping proteins and 
carboxylase enzymes are known as the common biotinylated proteins in many mammalian 
cells [26]. In both light and heavy cultures these enzymes were equally biotinylated which 
led to the equal abundance of their light and heavy versions. In our dataset, 6 of 7 total 
isoforms of 14-3-3, including 14-3-3β/α, γ, ε, η, θ and ζ/δ, were identified with a infinite 
L/H ratio (Supplemental Table 2 and Figure 6C, 6D, and 6F), which suggests their high 
affinity in binding to the 14-3-3ε isomer in the complex. Meanwhile, 20 proteins previously 
known to interact with 14-3-3ε were identified (Supplemental Table 2). Among them, the 
peptides of insulin receptor substrate 4 showed an approximate L/H of 4.4 which is the 
lowest ratio in comparing to other known 14-3-3ε interactors. We therefore used this ratio 
value as the threshold to distinguish other 14-3-3ε-specific interactors. As a result, a total of 
266 proteins were distinguished as the 14-3-3ε interacting partners from a single 
experimental run (Supplemental Table 2). Except for the 20 known interactors, a total of 246 
proteins were newly identified as the 14-3-3ε interacting partners. For example, non-pou 
domain-containing octamer-binding protein, NonO, was identified by 16 unique peptide 
signals with L/H ratio at an infinite value (Figure 6E), suggesting its specific enrichment 
with biotinylated 14-3-3ε through streptavidin magnetic microbeads. To validate the 
accuracy of our proteomic results we performed co-transfection and co-immunoprecipitation 
experiments and found that NonO strongly interacts with 14-3-3ε (Figure 6F).
Using currently available bioinformatics tools, STRING database, as shown in Supplemental 
Figure 1, close to 79% of our identified 14-3-3ε interactors were found to be interconnected 
by the proteins involving in a variety of cellular processes such as signal transduction, RNA 
processing, cell cycle control, DNA repair, cellular energy metabolism, etc. (Table 1). 
Functional characterization of other novel 14-3-3ε interacting proteins is under way and will 
be reported elsewhere.
4 Discussion
Here we demonstrate a novel integration of in vivo target-specific biotinylation, and efficient 
and high-yield affinity complex pull-down, and ‘in-spectra’ quantitative markers for precise 
screening of target protein-specific interactome. We have made significant improvements on 
our previously developed dual-tagging method [13]. Firstly, we substituted the epitope tag 
with relative low affinity such as Flag or Myc with an AP tag for in vivo biotinylation. This 
change leads to not only much stronger affinity for recognizing the target protein and 
therefore its associates in a complex, but also much higher efficiency and yield of affinity 
purification using streptavidin magnetic beads. Common TAP methods usually use relative 
long tags for affinity purification, which may inevitably interfere with protein interactions. 
To reduce possible effects on the existing native PPIs due to the size of an affinity tag here 
we used a shorter AP tag of 15 amino acids [18, 19, 24] for biotinylation than what was 
previously reported [17]. We then systematically evaluated the specificity of in vivo 
biotinylation of AP-tagged target protein and found highly specific biotinylation of target 
protein with minimum background biotinylation.
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Secondly, to avoid the tedious step of establishing a stable cell line we adapted the strategy 
of transient co-transfection. A major concern for transient transfection is the possibility of 
the overexpression of the tagged target protein which may lead to the components of the 
isolated complex departure from those formed in physiological conditions. It was not case 
for our design of co-transfecting both AP-tagged target protein and BirA biotin ligase. Using 
this approach of transient co-transfection, it only takes 3 days to obtain a protein complex, 
including cell culture, transfection, and complex purification, which is much shorter than 
what needed for a method of taking the steps of established stable cells. More importantly, 
for the study of interaction proteomics in primary cells as stable transfection is obviously not 
suitable for primary cells, transient transfections are feasible alternatives.
Thirdly, due to the strong affinity between biotin and avidin with binding constant of Kd at 
10−15 M, the biotin-tagged complex could be pulled down in high yield in competing with 
untagged endogenous counterpart for recruiting the interacting partners. As a result, we 
could significantly reduce the quality of the starting cells from 109 which are typically for 
the pull-down experiments using relative weak epitope tags [5] to 107. Meanwhile those 
weak or transient interactions could be preserved. In this regard, even successful in 
transfection, primary cells are not amenable to any TAP approach because of the limited 
cellular materials. Because our BioCAT method needs very small quantities of starting cells, 
it could allow the characterization of complexes in primary cells if using high-efficiency 
transfection method, e.g., lentivirus transfection, for these cells that are not easily tansfected.
It is inevitable that non-specific contaminants may also be pulled down in an IP complex 
even with high affinity tags such as biotin or optimized TAP tags [17, 27]. Similar to our 
previous ‘dual-tagging’ scheme, we use the ‘digitalized’ AACT/SILAC tags to distinguish 
the specific interators from those non-specific contaminants based on the quantitative L/H 
ratio (Supplemental Table 2). We observed an approximate 20% of totally identified 
proteins showing L/H close to 1 for non-specific contaminants which is much lower than 
what were found in the complex pulled down by anti-FLAG tag beads [13]. This suggested 
that high affinity isolation of IP complexes could result in less non-specific contaminants. 
Also we noticed that most of the specific interactors were identified with significantly higher 
L/H in the presence of biotin-tagged 14-3-3ε (Figure 5). In this study we used an empirical 
and relatively stringent value, i.e., 4.4-fold changes of particular protein abundance in the 
biotin-enriched complex, as the cut-off threshold for determining 14-3-3ε interacting 
partners in high confidence. For the first time, 6 of total 7 isomers in the 14-3-3 family were 
simultaneously identified as the specific interactors in the same IP complex. In addition to 
20 known interactors of 14-3-3 members, we have also identified 246 new interactors, which 
would shed light on the understanding of the undefined isomer-specific functions of 14-3-3ε. 
The newly identified interactors of 14-3-3ε by using BioCAT method allow us to extend the 
functional linkage of 14-3-3ε to a variety of biological processes (Supplemental Figure 1). 
For example, we have identified a set of 14-3-3ε interactors such as NonO at L/H 34.8 that 
was known to be involved in DNA damage response (Figure 6 and Table 1). Although many 
evidences suggest that only the 14-3-3σ isomer is involved in DNA damage/repair [28, 29], 
little is evidenced for possible 14-3-3ε involvement in DNA damage response. Our dataset 
of the profile of the 14-3-3ε interactors related to DNA damage response have now 
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suggested the functional link between 14-3-3ε and this particular biological process. Further, 
other interactors identified in the complex such as GBF1, ANKS1A, and API5, etc, 
indicated possible involvement of 14-3-3ε in Golgi biogenesis and protein trafficking 
[30-33], in growth factor receptor signaling pathways [34], and in apoptosis pathways [35], 
respectively. Thereby the multi-functional nature of 14-3-3ε isomers has then been 
illustrated by its interactions with the partners functional in diverse biological processes.
In summary, this BioCAT method represents a broadly applicable approach for precise 
screening of interaction proteome in mammalian cells. We conclude that this method has at 
least four major strengths including small quantities of the cells needed, short period of time 
for sample processing, high efficiency, and high MS signal specificity. Therefore, large-
scale and high-throughput explorations of the human interactome (and hence, more 
importantly, the dynamic interactome) and cellular machinery should become more feasible. 
Furthermore, by integrating the in vivo quantitative proteomic approach, e.g., the iTRAQ 
approach [36], our BioCAT method would provide an excellent tool for interaction 
proteomics in primary mammalian cells.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Analysis of the specificity and efficiency of the biotinylation of AP-tagged proteins 
through either in vivo or in vitro mechanism
The 293T cells were transiently transfected with the expression plasmid(s) as indicated. (A) 
Western blotting with streptavidin–HRP conjugate to detect biotinylated AP-tagged VAV1 
protein (VAV1-AP). Lane 2 indicates the exogenously expressed VAV1-AP protein was 
biotinylated in vivo by the co-expressing BirA biotin ligase. Lane 4 suggests the proteins 
were biotinylated in vitro using the BirA biotin ligase. For lanes 2 and 4, densitometry 
analysis was performed and the relative density of the band was given underneath the lanes. 
(B) Western blotting with streptavidin–HRP conjugate to detect biotinylated AP-1433 or 
1433-AP. Lane 1 indicates the cellular extract from nontransfected 293T cells. For lanes 7 
and 8, the proteins were biotinylated in vitro using the BirA ligase. (C) Western blotting 
with an anti-14-3-3ε antibody to detect endogenous and tagged exogenous 14-3-3ε proteins.
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Figure 2. Purification of AP-tagged proteins by streptavidin magnetic microbeads
Protein mixtures were separated by SDS-PAGE and stained by Coomassie Brilliant Blue. 
Lanes 1 and 10: protein size markers; Lane 2 indicates the purity of the biotinylated AP-
tagged MBP-AviTag protein; Lane 4 shows the un-biotinylated AP-tagged MBP-AviTag 
protein; Lane 6 indicates a mixture of the protein in lane 2 and lane 8; Lane 8 and 20 
indicate NK92MI cellular proteins treated with biotin ligase BirA in vitro; Lanes 3, 5, 7 and 
9: the proteins purified by streptavidin magnetic microbeads from the same protein mixtures 
shown in lanes 2, 4, 6 and 8, respectively. The star indicates the streptavidin molecule 
(monomer) that was dissociated from the biotinylated proteins after boiled in the SDS-
PAGE loading buffer. For lanes 2, 3 and 7, the densitometry analysis was performed and the 
relative density of the band was given underneath the bands.
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Figure 3. Purification of biotin-tagged protein and the associating complex by streptavidin 
magnetic microbeads
Lane 1 – the cellular extract from nontransfected 293T cells; Lane 2 – markers; Lanes 3 and 
4 - the AP-tagged proteins were biotinylated in vivo by co-expressed BirA. The proteins 
from the cells transfected with pAP-1433 or p1433-AP alone (lanes 5 and 6) were 
biotinylated in vitro using the BirA biotin ligase before purification as indicated in the 
Methods. The stars indicate the possible biotinylated AP-tagged 1433 proteins as compared 
to the results in Figure 1B and 1C. Following MS analysis, the protein identity in the bands 
indicated by rectangle was compared. For the purpose of comparison, the 293T cells were 
transfected with the expression plasmid pBirA or pAP-1433 alone, and then the protein 
mixtures were also purified by streptavidin magnetic microbeads. The purified elutes were 
then separated by SDS-PAGE (lanes 7 and 8).
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Figure 4. Schematic representation of BioCAT stretagy
Approximately 2.5 × 106 parental cells growing in the regular or ‘light’ medium (yellow 
dishes) were transiently transfected with an expression vector carrying the BirA gene (DS-
BirA) and an expression vector carrying the gene coding for bait protein (DS-bait), which 
was fused with the AP DNA sequence (DS-AP), while the same number of cells growing in 
the leucine-d3 containing or ‘heavy’ media (green dish) were transiently transfected with 
only the expression vector carrying the BirA gene. Following one-step purification using 
streptavidin magnetic microbeads, the immunoprecipitates from each cell pool were mixed 
and then separated by 1D-SDS-PAGE. The proteins in each gel band were tryptic digested 
followed by LC-MS/MS analysis. The peptides containing leu-d3 should show the mass 
shifts of 3 × n (n is the number of leucine in the peptide) with respect to the non-labeled or 
light counterparts. The proteins that specifically interact with the tagged bait protein as well 
as the nonspecific background binding proteins were distinguished by the light-to-heavy 
(L/H) ratio.
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Figure 5. The distribution of L/H ratio of the identified proteins in the AP-1433 complex
Each spot represents a MS-identified protein in Supplementary Table 2. The L/H ratio of 
each protein was shown with the empirical L/H threshold at 4.3 to determine those specific 
interators.
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Figure 6. MS spectra of the proteins identified by BioCAT and Validation of their interactions 
with 14-3-3ε
The peptide signals derived from tubulin β (A), acetyl-CoA carboxylase (B), 14-3-3ε (bait 
protein, (C)), 14-3-3ζ (D), and NonO (E) suggested those nonspecific binding (A, B) or 
those specifically enriched proteins (D, E). (F) Validation of the specifically enriched 
proteins in (D, E) by using western blotting.
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Table 1
Functional Categories of the Identified Interactors of 14-3-3ε in 293T Cell
Category Count
mRNA processing 42
cellular biosynthetic process 44
nucleobase, nucleoside, nucleotide and nucleic acid
metabolic process 90
RNA localization 12
biopolymer metabolic process 106
establishment of RNA localization 11
nucleobase, nucleoside, nucleotide and nucleic acid transport 11
cellular macromolecule metabolic process 74
regulation of biosynthetic process 13
regulation of translation 12
protein metabolic process 75
intracellular transport 24
ribonucleoprotein complex biogenesis and assembly 11
establishment of cellular localization 25
regulation of protein metabolic process 12
response to DNA damage stimulus 12
organelle organization and biogenesis 27
regulation of metabolic process 53
cellular component assembly 15
regulation of cellular process 71
cell cycle process 17
cell cycle phase 10
mitotic cell cycle 9
protein transport 15
cell death 17
regulation of cell cycle 12
negative regulation of biological process 22
Gene annotations of those specific interactors listed in Supplemental Table 2 were performed using the Functional Annotation Tool at DAVID site.
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